Hero

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association

1

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association

Celyad to Participate in Upcoming June 2019 Conferences

2

Celyad to Participate in Upcoming June 2019 Conferences

About Celyad

Making the Impossible Possible

Celyad is a clinical-stage biopharmaceutical that is developing next generation CAR-T NK cell-based immunotherapies for cancer treatment.

Latest News

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association

Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Participate in Upcoming June 2019 Conferences

Celyad to Present Data at 24th Congress of the European Hematology Association

Celyad to Present Data at 24th Congress of the European Hematology Association

Discover all news

Carousel

Social Feed

Celyad's team had a great time at #EHA2019! In case you didn't had a chance to meet our team, the posters are avail… https://t.co/qCekfohIPa

1 week ago

Celyad's team had a great time at #EHA2019! In case you didn't had a chance to meet our team, the posters are avail… https://t.co/qCekfohIPa

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association. #EHA2019… https://t.co/KahnAhQ53l

1 week ago

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association. #EHA2019… https://t.co/KahnAhQ53l

Attending #EHA2019 ? Come and listen to Dr Peggy Sotiropoulou, R&D Director at @CelyadSA. #GeneTherapy #EHA24… https://t.co/VR7ObG4sKq

1 week ago

Attending #EHA2019 ? Come and listen to Dr Peggy Sotiropoulou, R&D Director at @CelyadSA. #GeneTherapy #EHA24… https://t.co/VR7ObG4sKq

Don't miss this interview of @filpetti , CEO of @CelyadSA ! #BIO2019 #CART #cancertherapy https://t.co/qHaxWhtGhb

1 week ago

Don't miss this interview of @filpetti , CEO of @CelyadSA ! #BIO2019 #CART #cancertherapy https://t.co/qHaxWhtGhb

Celyad's team had a great time at #EHA2019! In case you didn't had a chance to meet our team, the posters are avail… https://t.co/qCekfohIPa

1 week ago

Celyad's team had a great time at #EHA2019! In case you didn't had a chance to meet our team, the posters are avail… https://t.co/qCekfohIPa

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association. #EHA2019… https://t.co/KahnAhQ53l

1 week ago

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology Association. #EHA2019… https://t.co/KahnAhQ53l

Attending #EHA2019 ? Come and listen to Dr Peggy Sotiropoulou, R&D Director at @CelyadSA. #GeneTherapy #EHA24… https://t.co/VR7ObG4sKq

1 week ago

Attending #EHA2019 ? Come and listen to Dr Peggy Sotiropoulou, R&D Director at @CelyadSA. #GeneTherapy #EHA24… https://t.co/VR7ObG4sKq

Don't miss this interview of @filpetti , CEO of @CelyadSA ! #BIO2019 #CART #cancertherapy https://t.co/qHaxWhtGhb

1 week ago

Don't miss this interview of @filpetti , CEO of @CelyadSA ! #BIO2019 #CART #cancertherapy https://t.co/qHaxWhtGhb